Michael Dennis

Professor Michael Dennis is an internationally recognised Consultant Haematologist and key opinion leader in myeloid malignancies, with particular expertise in acute myeloid leukaemia (AML). He qualified in Medicine from the University of Dundee in 1991 and completed his initial physician training in Liverpool before moving to Australia, where he undertook his first specialist training in haematology in Perth. On returning to the UK, he joined The Christie in 1996, completing his haematology training and being awarded an MD from the University of Liverpool. He was appointed Consultant Haematologist at The Christie in 2004, where he works on the haematology and transplant unit.

Throughout his career, Professor Dennis has held several senior leadership roles. He served as Clinical Director for the Haematology and Transplant Unit from 2004 to 2014 and as Haematological Cancer Pathway Director for Manchester Cancer from 2014 to 2017. During this time, and continuing to the present day, he has been the clinical lead for AML. In 2024, he was awarded a Manchester Academic Health Science Centre Clinical Chair by the University of Manchester’s Faculty of Biology, Medicine and Health, recognising his major contributions to haematology research.

Professor Dennis’s clinical practice focuses on the management of patients with myeloid diseases, including AML, chronic myeloid leukaemia, myelodysplastic syndromes and myeloproliferative disorders. His work frequently involves complex treatment pathways incorporating chemotherapy, clinical trials, and stem cell or bone marrow transplantation.

He is highly active in national and international research and is a core member of the UK AML Research Network. His roles include Chief Investigator for the LI-1 trial and Co-Chief Investigator for AML19, the leading frontline UK trials in AML. He is also involved with the National Cancer Research Network AML and myelodysplasia working groups and regularly acts as a clinical expert for NICE technology appraisals in AML.

Professor Dennis is a member of numerous professional organisations, including the European Group for Blood and Marrow Transplantation, the Royal College of Physicians, the Royal College of Pathologists, the European Haematology Association, the American Society of Hematology and the British Society for Haematology. He is a frequent invited speaker at national and international meetings and is widely regarded as an authority in the treatment and research of acute myeloid leukaemia.